Form 4: Perrigo Executive Alison Ives Reports Acquisition of Restricted Stock Units

EVP & Chief Scientific Officer of Perrigo Company plc, Alison Ives, reports the acquisition of 7,166 Restricted Stock Units (RSUs) on April 5, 2024.

Summary

• Alison Ives, EVP & Chief Scientific Officer of Perrigo Company plc, filed a Form 4 on April 9, 2024, reporting a transaction.
• On April 5, 2024, Ms. Ives acquired 7,166 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one Perrigo Company plc ordinary share.
• The RSUs vest in three equal annual installments beginning April 5, 2025.
• Ms. Ives directly owns 18,010 ordinary shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The acquisition of RSUs is generally a positive sign, but it's a standard practice.

Positives

• The acquisition of RSUs by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The RSUs vest in three equal annual installments beginning April 5, 2025, suggesting a multi-year incentive structure for the executive.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates changes in the beneficial ownership of Perrigo's securities by one of its executives.

Stakeholder Impact

• The acquisition of RSUs by a company executive can have a minor positive impact on shareholder confidence.

Key Dates